218 related articles for article (PubMed ID: 33203651)
1. Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS.
Engel S; Jolivel V; Kraus SH; Zayoud M; Rosenfeld K; Tumani H; Furlan R; Kurschus FC; Waisman A; Luessi F
Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33203651
[TBL] [Abstract][Full Text] [Related]
2. Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells.
Dobson L; Träger U; Farmer R; Hayardeny L; Loupe P; Hayden MR; Tabrizi SJ
J Neurochem; 2016 Jun; 137(5):782-94. PubMed ID: 26823290
[TBL] [Abstract][Full Text] [Related]
3. Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Jolivel V; Luessi F; Masri J; Kraus SH; Hubo M; Poisa-Beiro L; Klebow S; Paterka M; Yogev N; Tumani H; Furlan R; Siffrin V; Jonuleit H; Zipp F; Waisman A
Brain; 2013 Apr; 136(Pt 4):1048-66. PubMed ID: 23518712
[TBL] [Abstract][Full Text] [Related]
4. Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis.
Ferreira TB; Barros PO; Teixeira B; Cassano T; Centurião N; Kasahara TM; Hygino J; Vasconcelos CC; Filho HA; Alvarenga R; Wing AC; Andrade RM; Andrade AF; Bento CA
Brain Behav Immun; 2014 Oct; 41():182-90. PubMed ID: 24882215
[TBL] [Abstract][Full Text] [Related]
5. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity.
Schulze-Topphoff U; Shetty A; Varrin-Doyer M; Molnarfi N; Sagan SA; Sobel RA; Nelson PA; Zamvil SS
PLoS One; 2012; 7(3):e33797. PubMed ID: 22479444
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.
Zhang X; Tao Y; Wang J; Garcia-Mata R; Markovic-Plese S
Eur J Immunol; 2013 Jan; 43(1):281-9. PubMed ID: 23076801
[TBL] [Abstract][Full Text] [Related]
7. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
[TBL] [Abstract][Full Text] [Related]
8. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
9. Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects.
González-Oria MC; Márquez-Coello M; Girón-Ortega JA; Argente J; Moya M; Girón-González JA
J Neuroimmune Pharmacol; 2019 Sep; 14(3):413-422. PubMed ID: 30649665
[TBL] [Abstract][Full Text] [Related]
10. Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.
Thöne J; Ellrichmann G; Seubert S; Peruga I; Lee DH; Conrad R; Hayardeny L; Comi G; Wiese S; Linker RA; Gold R
Am J Pathol; 2012 Jan; 180(1):267-74. PubMed ID: 22152994
[TBL] [Abstract][Full Text] [Related]
11. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of interleukin-1β-mediated interleukin-1 receptor-associated kinase 4 phosphorylation by zinc leads to repression of memory T helper type 17 response in humans.
Lee H; Kim B; Choi YH; Hwang Y; Kim DH; Cho S; Hong SJ; Lee WW
Immunology; 2015 Dec; 146(4):645-56. PubMed ID: 26407164
[TBL] [Abstract][Full Text] [Related]
13. Nucleolin Mediates LPS-induced Expression of Inflammatory Mediators and Activation of Signaling Pathways.
Fang L; Wang KK; Huang Q; Cheng F; Huang F; Liu WW
Curr Med Sci; 2020 Aug; 40(4):646-653. PubMed ID: 32862374
[TBL] [Abstract][Full Text] [Related]
14.
Pan Q; Zhang Q; Chu J; Pais R; Liu S; He C; Eko FO
Front Cell Infect Microbiol; 2017; 7():514. PubMed ID: 29326885
[TBL] [Abstract][Full Text] [Related]
15. The role of laquinimod in modulation of the immune response in relapsing-remitting multiple sclerosis: Lessons from gene expression signatures.
Zilkha-Falb R; Gurevich M; Hayardeny L; Achiron A
J Neuroimmunol; 2015 Jun; 283():11-6. PubMed ID: 26004150
[TBL] [Abstract][Full Text] [Related]
16. Moderate alcohol intake in humans attenuates monocyte inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of interleukin 10.
Mandrekar P; Catalano D; White B; Szabo G
Alcohol Clin Exp Res; 2006 Jan; 30(1):135-9. PubMed ID: 16433741
[TBL] [Abstract][Full Text] [Related]
17. Effects of monomethylfumarate on dendritic cell differentiation.
Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
[TBL] [Abstract][Full Text] [Related]
18.
Glaser K; Silwedel C; Fehrholz M; Waaga-Gasser AM; Henrich B; Claus H; Speer CP
Front Cell Infect Microbiol; 2017; 7():484. PubMed ID: 29234642
[No Abstract] [Full Text] [Related]
19. Nerve growth factor downregulates inflammatory response in human monocytes through TrkA.
Prencipe G; Minnone G; Strippoli R; De Pasquale L; Petrini S; Caiello I; Manni L; De Benedetti F; Bracci-Laudiero L
J Immunol; 2014 Apr; 192(7):3345-54. PubMed ID: 24585880
[TBL] [Abstract][Full Text] [Related]
20. Laquinimod Protects Against TNF-α-Induced Attachment of Monocytes to Human Aortic Endothelial Cells (HAECs) by Increasing the Expression of KLF2.
Jiang T; Zhang W; Wang Z
Drug Des Devel Ther; 2020; 14():1683-1691. PubMed ID: 32440094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
